TPG-IHA hosted a series of webinars geared towards better understanding the COVID-19 pandemic and how it has impacted healthcare around the world. Using our contacts from previous live, in-person events in host countries, and faculty from future educational summits to be held when global travel normalizes, we’ve put together several hours of content. You can enjoy the video replays of each webinar, and some additional audio recordings where available that cover some of the audience questions that were asked but not answered during the event. We also have a list of all faculty participants below the videos.

 
Part I: “What Is The New Normal?”
December 2, 2020

The Academy hosted a panel of speakers representing viewpoints from Japan, Sweden, and the United States. You can watch the replay of the session below. Our speakers addressed a number of questions in this hour-long webinar, like:

How did your country respond to COVID-19 and why?
What have we learned from this pandemic?
What is the new “normal” for us all?
How are you dealing with a vaccine?
What is the plan for 2021 and beyond?

 

 

Part II: “Where Are We One Year Later?”
March 31, 2021

Part II of the series included speakers from Canada, Israel, Japan, and the United States. Our faculty took a look back at the previous year and assess how their respective countries handled the pandemic and where things sit currently, regarding both healthcare and the public.

We heard comments surrounding the adjustments made as entire populations were forced to work from home, or became unemployed. We discussed lockdowns, mask mandates, other government intervention and how the public responded to each of these attempts at controlling the coronavirus. And we became the conversation addressing vaccines, their availability, administering them to the public, and much more.

You can view the video replay of the 90-minute session below, and there are two audio-only recordings you can stream (about 10 minutes each) that discuss audience questions that we could not address during the event due to time restraints. Faculty information for this session is also available below.

Dr. Bruce Rosen joined Jeff Carlisle for a quick follow-up conversation to further discuss the impact of COVID-19 on the workforce and other social implications of the pandemic, as well as touching on the COVID-19 vaccine and the possibility of boosters in the future.

He also shared a study regarding the effects of working from home throughout the pandemic, which is available here.

 
Dr. Sayaka Hikida joined Jeff Carlisle for a quick follow-up conversation regarding the efficacy of mask-wearing and surface sanitation, and they touched briefly on how to address the possibility of another pandemic.

 

 

SPEAKER BIOGRAPHIES AND COMPANY PROFILES



Cohen Perry Cohen (Parts I & II)
Chief Executive Officer
The Pharmacy Group
Carmel, Indiana USA

Perry is co-founder and Chief Executive Officer of The Pharmacy Group (TPG). Perry has more than 40 years of experience with managed care, and during that time has worked for local, regional, and national health plans. He helped create the pharmacy benefit management (PBM) industry in the early 1990s. Over the years he has developed relationships with hundreds of decision-makers in the United States healthcare system and has assisted more than 200 companies in selling their products and services to payors. Additionally, Perry practiced in community, hospital, and long-term care pharmacy in California and oversaw the operations of 50 community pharmacies in nine states. Perry is a co‐founder, past president, and fellow of the Academy of Managed Care Pharmacy (AMCP), a member of the Drug Topics Editorial Advisory Board, Managed Healthcare Executive Editorial Advisory Board, and the University of Arizona College of Pharmacy National Advisory Board. He completed an administrative clerkship at the Food and Drug Administration in Rockville, Maryland. His clinical training was performed at Tripler Army Medical Center in Honolulu, Hawaii.

About The Pharmacy Group
The Pharmacy Group (TPG) and its family of companies offer consulting services to payors, information technology, healthcare services and pharmaceutical companies to grow revenue and enhance their financial performance. The TPG Family consists of: The Pharmacy Group; TPG Data Services; TPG Healthcare Consulting, TPG International Health Academy; TPG National Payor Roundtable. The TPG Family of Companies has diverse experience in all facets of healthcare.

For 17 years, we have provided our clients unparalleled service, support and solutions to better manage their organizations. Our key services include:

  • Consulting
  • Data Analysis
  • Educational Programs
  • Market Research
  • Sales Support

TPG and its family of companies works with our clients to expand their market penetration and grow the revenue of their products and services. For more information, please visit www.tpg-group.com.


Hall Don Hall, MPH (Parts I & II)
Principal
DeltaSigma, LLC
Highlands Ranch, Colorado USA

Don Hall, M.P.H., has experience in all aspects of non-profit and for-profit healthcare management, including public health, hospital systems, and health plans. His extensive background includes executive level positions with Hospital Corporation of America, Lincoln National Corporation, EQUICOR and Blue Cross and Blue Shield of Texas. Before becoming a founding partner of DeltaSigma, LLC in 2006, Don served for eight years as President and CEO of Colorado Access, a non-profit provider-sponsored health plan focusing on Medicaid, SCHIP, Medicare Advantage special needs populations, and corrections care. Don has been a member of the Academy of International Health Studies since 2002 and has studied health care systems in Argentina, Germany, Italy, Ireland, Sweden and Switzerland. In addition, Don serves on the Editorial Advisory Board for the Managed Healthcare Executive magazine. He received his M.P.H. in Epidemiology from the University of Oklahoma Health Sciences Center. DeltaSigma, LLC is a national healthcare consulting practice that focuses on supporting innovative approaches to business strategies within Commercial, Medicaid, Medicare and MLTSS health plans.

About DeltaSigma, LLC
DeltaSigma, LLC is a healthcare consulting practice that creates plans for dramatic results for its clients. The company offers innovative approaches that focus on developing strategic business, diversification and marketing plans; creating communication programs; evaluating and developing opportunities for outsourcing, accessing capital, and partnerships as a means of strategic market positioning; and, assessing organization structures to maximize alignment with operations and customers.

Expertise

  • Developing new lines of business, including Medicaid, Medicare Advantage Special Needs Plan (dual eligible), long-term care, individual and group health insurance products, healthcare exchange and integrated care products
  • Developing strategic business, diversification and marketing plans that take into account customer requirements, competitive environment and industry trends
  • Enhancing operating results by identifying the means to:
    • Maximize current revenue
    • Develop new revenue sources consistent with existing resources
    • Reduce healthcare costs while improving quality
    • Provide alternative care delivery models for high cost members
    • Include the services of appropriate vendors or service providers
  • Leveraging business relationships and expertise to provide growth opportunities for our clients
  • Assessing organizational structures to maximize alignment with operations and customers
  • Evaluating best practices and solutions related to organizational structures, use of technology, network management and clinical approaches
  • Facilitating management and Board scenario and strategic planning sessions

Davidovitch Nadav Davidovitch, MD, MPH, PhD (Part II)
Director, School of Public Health, Faculty of Health Sciences
Ben-Gurion University of the Negev
Jerusalem, Israel

Nadav Davidovitch, MD, MPH, PhD, is an epidemiologist and public health physician. He is a full professor and director of the School of Public Health at the Faculty of Health Sciences, Ben-Gurion University of the Negev in Israel. His research interests include health policy,public health, vaccination policy, one health/eco-health, comparative health care systems, public health ethics and global health.

Davidovitch serves on several international and national committees, among them: Governing Board, European Public Health Association; Association of Schools of Public Health in the European Region COVID-19 Task Force; and the Israel national COVID-19 advisory committee.

About Ben-Gurion University of the Negev
Ben-Gurion University of the Negev is one of Israel’s leading research universities and among the world leaders in many fields.

It has around 20,000 students and 4,000 faculty members in the Faculties of Engineering Sciences; Health Sciences; Natural Sciences; the Pinchas Sapir Faculty of Humanities and Social Sciences; the Guilford Glazer Faculty of Business and Management; the Joyce and Irving Goldman School of Medicine; the Kreitman School of Advanced Graduate Studies; and the Albert Katz International School for Desert Studies. More than 100,000 alumni play important roles in all areas of research and development, industry, health care, the economy, society, culture and education in Israel.

The University has three main campuses: The Marcus Family Campus in Beer-Sheva; the research campus at Sde Boker and the Eilat Campus, and is home to national and multi-disciplinary research institutes: the National Institute for Biotechnology in the Negev; the National Institute of Solar Energy; the Ilse Katz Institute for Nanoscale Science and Technology; the Jacob Blaustein Institutes for Desert Research; the Ben-Gurion Research Institute for the Study of Israel & Zionism, and Heksherim – The Research Institute for Jewish and Israeli Literature and Culture.


Rosen Bruce Rosen, MD (Part II)
Director of Systems Research Group
Myers-JDC-Brookdale Institute
Jerusalem, Israel

Dr. Bruce Rosen is the director of the Systems Research Group at the Myers-JDC-Brookdale (MJB) Institute in Jerusalem. In that capacity he is a member of MJB’s senior management team, with responsibility for MJB’s research teams in the areas of health, employment, and the Arab population, as well as the Institute’s economic service. Dr. Rosen is also the director of MJB’s Smokler Center for Health Policy Research. His recent research foci have included Israel’s COVID-19 vaccination rollout, the Israeli mental health reform, efforts to monitor and improve the quality of care, health information exchanges, and the cross-national flow of health policy innovations. An important component of his work involves promoting linkages between research and health policy development. Dr. Rosen is also co-editor of the Israel Journal of Health Policy Research, which seeks to promote intensive intellectual interactions between scholars from Israel and their counterparts from around the world. Rosen holds a B.A. in economics from Harvard College and a doctorate in health policy from the Harvard School of Public Health.

About Myers-JDC-Brookdale Institute
Founded in 1974, the Myers-JDC-Brookdale Institute is Israel’s leading center for applied social research. The Institute identifies and examines key social challenges. We use our knowledge and research to help inform policy, advise programming, and improve services for individuals, families, and communities. We work to strengthen Israeli society and the wellbeing of all its members.

MJB is an independent, non-profit partnership between the Joint Distribution Committee, the Government of Israel, and the David and Inez Myers Foundation of Cleveland. The Institute’s governance committee is composed of senior government officials from the ministries of Labor and Social Affairs, Education, Health, and Finance, and Israel’s National Insurance Institute, and major lay leaders in the Jewish world.

VISION
The Myers-JDC-Brookdale Institute is Israel’s leading center for applied social research. We strengthen Israeli society by using meticulous study, rigorous research and our extensive knowledge to help improve decisions that impact people’s wellbeing.

MISSION
The Institute identifies and examines key social challenges. We use our research to help inform policy, advise programming, and improve services for individuals, families, and communities. We work to strengthen Israeli society and the wellbeing of all its members.

VALUES

  • Excellence and professionalism: Constant striving for professional improvement, which positions us as leaders in our field
  • Cooperation and collaboration: Active pursuit of internal and external partnerships, in order to jointly achieve our shared goals
  • Curiosity and creativity: Curiosity to question, to investigate and to learn, and creativity in practice and process
  • Integrity and courage: Resolute adherence to moral principles and to objective research and reporting
  • Community and responsibility: Respect and support of others; social sensitivity and tolerance; appreciation of cultural diversity

Laron Michal Laron (Part II)
Senior Research Scholar, Health Team Leader,
Systems Group, and Researcher, Pathfinder Team
Myers-JDC-Brookdale
Jerusalem, Israel

Senior Research Scholar, Health Team Leader, Systems Group, and Researcher, Pathfinder Team, the Myers-JDC-Brookdale Institute (MJB), Israel’s leading center for applied social research. Michal Laron has worked at MJB since 2012. As a researcher in the Aging Team (Family Group), her main research areas were coping with dementia, loneliness in old age, and integrated care. As a researcher in the Pathfinder Team, Michal addressed the issue of affordable housing. Since assuming office as Health Team Leader in 2020, Michal has led studies on health behaviors during the COVID-19 pandemic, remote health care services, and health and digital literacy. Michal holds a BA in Sociology and Communications an MA in Anthropology and Sociology, both from the Hebrew University of Jerusalem, as well as a PhD in Sociology from Tel Aviv University.

About Myers-JDC-Brookdale Institute
Founded in 1974, the Myers-JDC-Brookdale Institute is Israel’s leading center for applied social research. The Institute identifies and examines key social challenges. We use our knowledge and research to help inform policy, advise programming, and improve services for individuals, families, and communities. We work to strengthen Israeli society and the wellbeing of all its members.

MJB is an independent, non-profit partnership between the Joint Distribution Committee, the Government of Israel, and the David and Inez Myers Foundation of Cleveland. The Institute’s governance committee is composed of senior government officials from the ministries of Labor and Social Affairs, Education, Health, and Finance, and Israel’s National Insurance Institute, and major lay leaders in the Jewish world.

VISION
The Myers-JDC-Brookdale Institute is Israel’s leading center for applied social research. We strengthen Israeli society by using meticulous study, rigorous research and our extensive knowledge to help improve decisions that impact people’s wellbeing.

MISSION
The Institute identifies and examines key social challenges. We use our research to help inform policy, advise programming, and improve services for individuals, families, and communities. We work to strengthen Israeli society and the wellbeing of all its members.

VALUES

  • Excellence and professionalism: Constant striving for professional improvement, which positions us as leaders in our field
  • Cooperation and collaboration: Active pursuit of internal and external partnerships, in order to jointly achieve our shared goals
  • Curiosity and creativity: Curiosity to question, to investigate and to learn, and creativity in practice and process
  • Integrity and courage: Resolute adherence to moral principles and to objective research and reporting
  • Community and responsibility: Respect and support of others; social sensitivity and tolerance; appreciation of cultural diversity

Keller Elizabeth Keller (Part II)
Vice President, Business Development & Stakeholder Relations
OntarioMD
Toronto, Canada

Elizabeth Keller is a leading executive, strategist and integrator in Canadian digital health and a recognized health expert internationally. She was recently named as one of the Top 10 Women in Digital Health in Canada.

She has worked with some of the largest private sector consulting firms in the world (IBM and PwC), and in the public sector for the last 10 years. As VP, Business Development & Stakeholder Relations for OntarioMD, Elizabeth leads new business, partnerships, branding, marketing and communications, reports directly to the CEO and works closely senior leadership and key stakeholders across Canada.

Elizabeth is now an advisor to the Board for CHIEF (Canada’s Health Informatics Executive Forum) and also the Head of Delegation for Canada for ISO TC 215 (Digital Health Standards) for the Standards Council of Canada.

About OntarioMD
Your Trusted Advisor for EMRs and Provincial Digital Health Tools

OntarioMD supports physician practices in the selection, implementation and adoption of electronic medical records (EMRs) and other digital health and virtual care tools. Over 20,000 physicians and more than 1,500 nurse practitioners are enrolled in our programs. We have a successful track record in developing and implementing provincial digital health tools that are integrated with EMRs based on physicians’ needs. Our award-winning Health Report Manager (HRM), eNotifications and Insights4Care Dashboard tools, and our work to deploy and integrate eConsult with certified EMRs, demonstrate the value of our digital health services to enhance patient care.

OntarioMD is a wholly-owned subsidiary of the Ontario Medical Association. It is funded by the Ontario Ministry of Health, not from OMA members’ dues.


Hikida Sayaka Hikida, MD (Parts I & II)
Infectious Disease Emergency Specialist (IDES) Trainee
Ministry of Health, Labour and Welfare, Infectious Diseases Control Division
Tokyo, Japan

Sayaka Hikida is an Infectious Disease Emergency Specialist (IDES) trainee as well as a Fellow of the Japanese Society of Internal Medicine (FJSIM). After nine-years engagement to the rural medicine and a 2018 Japanese fellowship program in the US Naval hospital Yokosuka, she has been participating in the Infectious Disease Emergency Specialist (IDES) training program, offered by the Japanese Ministry of Health, Labour and Welfare (MHLW). After she worked at Novel Coronavirus Response Headquarters of MHLW, she has deployed to the US Centers for Disease Control (CDC) in Atlanta as a guest researcher/Japanese liaison medical officer Apr 2020-Mar 2021.

About IDES
The experience of Ebola disease outbreak in West Africa shed the light on the need of Japanese infectious disease experts who can contribute to the global health threat. The Japanese Ministry of Health, Labour and Welfare launched the Infectious Disease Emergency Specialist (IDES) training program in 2015 to tackle the emerging/ re-emerging infectious diseases, and established the structure for providing human resources internationally, as well as strengthened the domestic infectious disease emergency management.

VALUE

  • General knowledge and capability for administrative management and international coordination, as well as clinical experience and epidemiological knowledge of infectious disease.
  • Communication; Leadership, Teamwork, and Communication with the international agencies.
  • Information management; Collection, Assessment, and Publication.

Yasin Zayed Yasin, MD, MBA (Part I)
Chief Executive Officer
YA Health Advisors
Stockholm, Sweden

Zayed Yasin, MD/MBA is a physician executive specializing in using innovative technology to improve healthcare access and performance. While at the Brigham and Women’s Hospital/Harvard Medical School, he helped design, build and implement a comprehensive information platform as a basis for a system of Data Driven Strategic Planning for Region Halland in Sweden. He has published on innovation in the Swedish Healthcare system with Professor Michael Porter at Harvard Business School, and been involved with the Swedish health system since 2009. He currently works to bring new health innovations to market and develop better uses of health data in both the US in Sweden. Zayed lives with his wife and 3 daughters in Gothenburg, Sweden. He is the founder and CEO of YA Health Solutions, a healthcare technology development and advisory firm, and a Clinical Instructor in Emergency Medicine at Sahlgrenska University Hospital.

About YA Health Advisors

Yasin Advisors LLC is a boutique health innovation, technology, and services company supporting healthcare transformation through strategic advisory and technology development.

Key project include:
– Developing a US market entry strategy for a leading European VC-backed AI-clinical imaging startup
– Building a multi-channel patient engagement platform using Natural Language Processing to automate clinical and administrative encounters
– Re-engineering specialty care delivery for a publicly listed Swedish healthcare corporation, using advanced analytics to create a data-driven method for improving outcomes and decreasing costs